U.S. drug prices should reflect value to patients: expert panel

BOSTON/NEW YORK (Reuters) - A panel of medical experts said on Friday the prices of prescription medicines in the United States need to be brought in line with the value they bring to patients instead of continuing to let drugmakers set any price they choose.